GGrantIndex
← Search

Population Facing Research

$99,611P30FY2023CANIH

Beckman Research Institute/City Of Hope, Duarte CA

Investigators

Linked publications, trials & patents

Trial NCT07664670Trial NCT07664579Trial NCT07650656Trial NCT07628894Trial NCT07619599Trial NCT07612085Trial NCT07611370Trial NCT07608627Trial NCT07608458Trial NCT07608445Trial NCT07595874Trial NCT07590583Trial NCT07583810Trial NCT07583303Trial NCT07582172Trial NCT07582159Trial NCT07578077Trial NCT07578025Trial NCT07544992Trial NCT07365306Trial NCT07363408Trial NCT07293403Trial NCT07288034Trial NCT07278856Trial NCT07275216Trial NCT07271355Trial NCT07235501Trial NCT07226544Trial NCT07226102Trial NCT07225855Trial NCT07225738Trial NCT07220447Trial NCT07219147Trial NCT07218913Trial NCT07218718Trial NCT07218692Trial NCT07218510Trial NCT07210086Trial NCT07202247Trial NCT07184294Trial NCT07136493Trial NCT07133997Trial NCT07128680Trial NCT07126301Trial NCT07125729Trial NCT07042438Trial NCT07040982Trial NCT07037004Trial NCT07025564Trial NCT07025538Trial NCT07020533Trial NCT07003100Trial NCT06996119Trial NCT06985784Trial NCT06954831Trial NCT06922604Trial NCT06918431Trial NCT06910761Trial NCT06860815Trial NCT06859008Trial NCT06834126Trial NCT06815029Trial NCT06815003Trial NCT06780787Trial NCT06763341Trial NCT06763328Trial NCT06735690Trial NCT06735664Trial NCT06731894Trial NCT06675136Trial NCT06675123Trial NCT06672224Trial NCT06626256Trial NCT06625619Trial NCT06581211Trial NCT06580015Trial NCT06575725Trial NCT06575686Trial NCT06575296Trial NCT06572631Trial NCT06572618Trial NCT06572605Trial NCT06549478Trial NCT06543381Trial NCT06538389Trial NCT06500377Trial NCT06498973Trial NCT06454409Trial NCT06454383Trial NCT06453044Trial NCT06447987Trial NCT06440850Trial NCT06408220Trial NCT06399419Trial NCT06328621Trial NCT06287944Trial NCT06260033Trial NCT06249282Trial NCT06196008Trial NCT06195891

Abstract

Abstract Shared Resource 09: Population-Facing Research (PFR-SR) The Population-Facing Research Shared Resource (PFR-SR), established as a Developing SR in January 2018, aims to provide state-of-the-art technology services and consultation for population-facing researchers research (e.g. real-time evaluation of pollution exposures in individuals commuting in Los Angeles traffic; high-resolution genetic admixture studies with precise identification of Indigenous and African tribal ancestry; device technology to measure the impact of a behavioral intervention on movement – sitting, standing, walking, running). Specific Aims of PFR-SR: Aim 1. Develop curation and analytic tools to evaluate cancer risk on multiple levels of scale (populations - cohort curation; neighborhoods - real-time analysis of the built environment; individuals - evaluate movement of individuals participating in risk-assessment and behavioral trials). Aim 2. Provide tools to investigate the impact of ancestry and environmental exposures on cancer risk. Aim 3. Consultation and experimental design expertise for new and established investigators. Population-facing research is becoming more complex; increasingly studies incorporate device technology, high- resolution genetic admixture analysis, and evaluate, in real-time, the interaction between trial subjects and the built environment. In response, the PFR-SR provides services that 1) require high-level expertise and 2) cannot be accomplished by single investigators alone in a cost-effective manner. Users include all five COHCCC programs and reflect the breath of scientific expertise of COHCCC population-facing researchers. Many of our services are information technology-based and/or consultation and design, therefore our overhead is low; this allows us to be nimble and rapidly respond to the rapidly changing technology needs of our users. PFR-SR services are focused on NIH/NCI-funded science and determined by a survey of key members. Key services are vetted by the Shared Resources Steering Committee, PFS-SR Internal Advisory Board, and our COHCCC External Advisory Board. The PFR-SR Director meets biannually with SR Leaders from Research Pathology and Biostatistics & Mathematical Oncology. This bi-directional communication ensures that 1) PFR- SR services synergize with services provided by other SRs and are non-duplicative and 2) there is seamless translation of data and information from one SR to the next. Members Utilization by %Revenue 2017–21: 100 Total (14.1 MCBC, 2 DCT, 0.3 CI, 0.9 HM, 82.7 CCPS) Publications by Members: 34, 7 with Impact Factor >10 Grants Supported: 21 Total (1 DoD, 10 NCI of 17 NIH (11 R01, 2 U01))

View original record on NIH RePORTER →